- January 16, 2024
- 1:00 PM - 4:00 PM ET
- Organized By:
Recording and presentations
BAA Question and Answers
Responses to questions asked at the FY24 FDA Broad Agency Announcement Questions and Answers Session are now available.
FY24 FDA Broad Agency Announcement Questions and Answers Session
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. FY24 FDA BAA Q&A Session will provide an opportunity to the applicants to learn more about the application process. Join us to learn more about the FY24 BAA application process, next steps, and clarify any questions on how to apply.
Please register in advance to attend this event. Upon registering, you will receive an email including log-in information, and downloadable calendar reminder. There is no cost to attend, and you may cancel your registration at any time. FY24 FDA BAA Q & A session will be open to public. This meeting will be recorded and recording of the full event (including closed captioning and an audio transcript), presentation slides, responses to polls, and answers to all questions (received via email to FDABAA mailbox and live) will be posted.
The FDA BAA is open to all responsible sources, and small businesses are strongly encouraged to respond. Offerors may include single entities or teams from private sector organizations, Federally Funded Research and Development Centers (FFRDCs), and/or academic institutions, recipients of early concept paper recommendations (submit or do not submit), potential FY24 applicants.
Agenda and speaker information
Agenda and Speaker bios are available under Event Materials at the bottom of this page.
All times are Eastern Standard Time.
Submission Etiquette and Communication
# Template Dos and Don'ts
# Required documents
Dr. Kinnera Chada, ORSI
Mr. Ian Weiss, OAGS
# Question and Answer Panel
# Review of questions submitted via webinar Q&A pod, and in advance to FDABAA@fda.hhs.gov
Panel Members: ORSI & OAGS
|Adjourn and Closing Remarks
Note: Recording of the full event (including closed captioning and an audio transcript), presentation slides, responses to polls, and answers to all questions (received via email to FDABAA mailbox and live) will be posted below.
Fiscal Year 2024 (FY24) BAA solicitation
FDA solicits for advanced research and development proposals to support regulatory science and innovation. FDA anticipates that research and development activities awarded under this BAA will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation. View the FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science on SAM.gov. Please note that the application process for FY24 BAA has been updated.
Contact us / submit a question
Questions may be submitted in advance. Please contact FDABAA@fda.hhs.gov with questions, including any questions you would like us to answer at this event.
Information for Previous event
|2024 BAA External QA Session Agenda
|pdf (231.14 KB)
|2024 BAA Questions and Answers session bios-book
|pdf (269.29 KB)
|BAA Q&A Session January 16 2024-Ian Weiss Slides
|pdf (666.56 KB)
|BAA Q&A Session January 16 2024 Poll Responses
|pdf (45.95 KB)
|BAA Q&A Session January 16, 2024 Questions Responses.pdf
|pdf (346.52 KB)
|BAA Q&A Session January 16 2024-Kinnera Chada Presentation
|pdf (920.99 KB)